Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AOP2014 pre-filled pen self-administration study in polycythemia vera
2014-001356-31Phase 3Completed
- Sponsor
- AOP Health
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ropeginterferon alfa-2b in polycythemia vera (PV), sponsored by AOP Health. Primary endpoint: Ease of self-administration. Started Mar 2015; status: completed.
02
Drugs
ropeginterferon alfa-2b
03
Conditions
polycythemia vera (PV)
Beyond the preview
Go deeper on 2014-001356-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001356-31.